Literature DB >> 8773614

Missense mutations of the PS-1/S182 gene in German early-onset Alzheimer's disease patients.

R Sandbrink, D Zhang, S Schaeffer, C L Masters, J Bauer, H Förstl, K Beyreuther.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8773614     DOI： 10.1002/ana.410400225

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  5 in total

1.  Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.

Authors:  D Campion; C Dumanchin; D Hannequin; B Dubois; S Belliard; M Puel; C Thomas-Anterion; A Michon; C Martin; F Charbonnier; G Raux; A Camuzat; C Penet; V Mesnage; M Martinez; F Clerget-Darpoux; A Brice; T Frebourg
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

2.  Protein aggregates and novel presenilin gene variants in idiopathic dilated cardiomyopathy.

Authors:  Davide Gianni; Airong Li; Giuseppina Tesco; Kenneth M McKay; John Moore; Kunal Raygor; Marcello Rota; Judith K Gwathmey; G William Dec; Thomas Aretz; Annarosa Leri; Marc J Semigran; Piero Anversa; Thomas E Macgillivray; Rudolph E Tanzi; Federica del Monte
Journal:  Circulation       Date:  2010-03-01       Impact factor: 29.690

3.  De novo presenilin 1 mutations are rare in clinically sporadic, early onset Alzheimer's disease cases. French Alzheimer's Disease Study Group.

Authors:  C Dumanchin; A Brice; D Campion; D Hannequin; C Martin; V Moreau; Y Agid; M Martinez; F Clerget-Darpoux; T Frebourg
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

Review 4.  Alzheimer's disease genetics: from the bench to the clinic.

Authors:  Celeste M Karch; Carlos Cruchaga; Alison M Goate
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

Review 5.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.